Sanofi India Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 29, 2024, 9:09 pm

Market Cap	14,076 Cr.
Current Price	6,112
High / Low	7,600/4,606
Stock P/E	33.4
Book Value	298
Dividend Yield	2.73 %
ROCE	71.1 %
ROE	51.5 %
Face Value	10.0
PEG Ratio	15.90

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Sanofi India Ltd

Competitors of Sanofi India Ltd

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
MPS Pharmaa Ltd	8.05 Cr.	4.21	4.33/2.79		0.80	0.00 %	9.15 %	34.9 %	10.0
Gujarat Themis Biosyn Ltd	3,317 Cr.	304	390/170	62.9	20.5	0.22 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	59.8 Cr.	80.5	94.9/27.0	22.9	11.9	0.00 %	9.72 %	3.44 %	10.0
Gujarat Inject (Kerala) Ltd	33.8 Cr.	23.0	27.0/8.74	43.8	6.64	0.00 %	2.65 %	2.08 %	10.0
Godavari Drugs Ltd	85.8 Cr.	114	155/87.0	12.9	55.4	0.00 %	14.4 %	15.5 %	10.0
Industry Average	19,377.49 Cr	1,181.13		55.42	184.74	0.31%	16.14%	16.48%	6.30

All Competitor Stocks of Sanofi India Ltd

Quarterly Result

Month	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Sales	789	754	688	707	699	692	672	736	515	715	694	511	464
Expenses	542	556	561	512	538	510	505	507	393	506	506	374	348
Operating Profit	247	199	127	194	161	182	167	230	122	208	187	137	116
OPM %	31%	26%	18%	28%	23%	26%	25%	31%	24%	29%	27%	27%	25%
Other Income	17	504	16	142	16	11	34	44	57	12	12	41	21
Interest	0	0	0	0	0	0	0	0	1	0	0	0	0
Depreciation	21	14	11	11	11	10	10	10	9	10	10	9	9
Profit before tax	243	688	132	326	166	182	190	264	169	210	189	169	127
Tax %	26%	23%	32%	27%	27%	28%	31%	28%	27%	28%	27%	19%	19%
Net Profit	178	530	90	238	120	131	131	190	123	152	138	137	103
EPS in Rs	77.52	230.35	39.30	103.65	52.35	56.91	56.91	82.78	53.43	66.17	59.87	59.39	44.96

Last Updated: October 25, 2024, 4:12 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: October 25, 2024, 4:12 pm

Month	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	TTM
Sales	1,573	1,809	1,977	2,193	2,367	2,460	2,771	3,071	2,902	2,957	2,770	2,851	2,383
Expenses	1,261	1,411	1,639	1,817	1,832	1,921	2,146	2,403	2,186	2,194	2,066	2,047	1,734
Operating Profit	312	398	339	376	535	538	625	667	716	762	704	804	649
OPM %	20%	22%	17%	17%	23%	22%	23%	22%	25%	26%	25%	28%	27%
Other Income	41	83	131	218	66	79	88	33	45	564	204	83	86
Interest	1	0	0	0	2	1	1	0	2	2	2	2	1
Depreciation	90	92	97	113	119	102	103	100	82	67	42	40	38
Profit before tax	262	388	373	481	480	515	610	600	677	1,258	864	846	695
Tax %	32%	32%	29%	33%	37%	37%	38%	31%	29%	25%	28%	29%
Net Profit	177	265	264	322	304	326	381	414	478	944	621	603	530
EPS in Rs	76.81	115.30	114.61	139.78	132.26	141.74	165.48	180.09	207.65	410.61	269.83	262.26	230.39
Dividend Payout %	43%	39%	39%	46%	51%	50%	51%	194%	176%	119%	211%	64%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:	5%
5 Years:	1%
3 Years:	-1%
TTM:	-9%

Compounded Profit Growth
10 Years:	9%
5 Years:	9%
3 Years:	5%
TTM:	-9%

Stock Price CAGR
10 Years:	11%
5 Years:	7%
3 Years:	8%
1 Year:	24%

Return on Equity
10 Years:	22%
5 Years:	27%
3 Years:	33%
Last Year:	52%

Last Updated: Unknown

Balance Sheet

Last Updated: Unknown

Month	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Jun 2024
Equity Capital	23	23	23	23	23	23	23	23	23	23	23	23	23
Reserves	1,181	1,324	1,463	1,604	1,860	2,003	2,196	2,419	2,096	2,203	1,253	992	662
Borrowings	0	0	0	0	0	0	0	0	23	25	24	19	22
Other Liabilities	427	532	742	778	658	751	765	802	777	811	772	681	654
Total Liabilities	1,631	1,878	2,228	2,405	2,541	2,778	2,984	3,244	2,918	3,061	2,072	1,715	1,360
Fixed Assets	699	699	648	877	817	769	733	499	464	334	306	315	302
CWIP	43	136	210	22	34	30	21	17	10	13	24	16	29
Investments	0	0	0	0	0	0	0	0	0	0	0	2	0
Other Assets	888	1,043	1,369	1,505	1,690	1,978	2,230	2,728	2,444	2,714	1,743	1,382	1,029
Total Assets	1,631	1,878	2,228	2,405	2,541	2,778	2,984	3,244	2,918	3,061	2,072	1,715	1,360

Reserves and Borrowings Chart

Cash Flow

Month	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023
Cash from Operating Activity +	290	273	265	213	322	435	374	412	611	559	399	231
Cash from Investing Activity +	-5	-335	61	36	-155	-79	-73	66	276	631	651	36
Cash from Financing Activity +	-90	-105	-122	-147	-180	-188	-197	-183	-810	-849	-1,583	-878
Net Cash Flow	195	-168	205	102	-13	168	104	295	78	341	-533	-612

Free Cash Flow

Month	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023
Free Cash Flow	312.00	398.00	339.00	376.00	535.00	538.00	625.00	667.00	693.00	737.00	680.00	785.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023
Debtor Days	23	24	21	24	22	29	21	27	19	18	17	17
Inventory Days	135	151	179	173	169	151	154	127	107	110	125	202
Days Payable	75	83	122	81	79	119	110	100	93	105	109	89
Cash Conversion Cycle	83	92	78	115	112	61	65	54	33	22	33	130
Working Capital Days	3	43	26	9	79	17	18	35	-7	-19	-18	25
ROCE %	23%	29%	22%	26%	27%	26%	29%	28%	32%	35%	41%	71%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	60.40%	60.40%	60.40%	60.40%	60.40%	60.40%	60.40%	60.40%	60.40%	60.40%	60.40%	60.40%
FIIs	9.22%	8.99%	8.71%	8.26%	6.99%	6.71%	6.72%	6.80%	6.31%	6.11%	5.81%	5.78%
DIIs	19.05%	18.65%	18.59%	18.28%	19.22%	19.46%	19.65%	21.68%	22.51%	22.88%	22.60%	22.62%
Public	11.33%	11.96%	12.30%	13.08%	13.41%	13.43%	13.22%	11.10%	10.78%	10.61%	11.21%	11.20%
No. of Shareholders	50,916	59,276	64,542	73,734	74,593	76,694	71,513	68,598	62,870	61,849	67,662	66,211

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Aditya Birla Sun Life Frontline Equity Fund	268,508	0.84	216.62	196,342	2024-12-29	36.76%
Nippon India Pharma Fund	236,008	2.94	190.4	196,342	2024-12-29	20.2%
Nippon India Growth Fund	226,766	0.78	182.94	196,342	2024-12-29	15.5%
Nippon India Small Cap Fund	196,342	0.36	158.4	196,342	2024-12-29	0%
SBI Contra Fund	161,000	0.68	129.5	196,342	2024-12-29	-18%
Nippon India Multi Cap Fund	152,371	0.5	122.93	196,342	2024-12-29	-22.4%
SBI Long Term Equity Fund	147,988	0.69	119.04	196,342	2024-12-29	-24.63%
Aditya Birla Sun Life Small Cap Fund	144,433	2.22	116.52	196,342	2024-12-29	-26.44%
SBI Magnum Midcap Fund	100,837	0.56	81.11	196,342	2024-12-29	-48.64%
Aditya Birla Sun Life Multi-Cap Fund	87,342	1.43	70.46	196,342	2024-12-29	-55.52%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Dec 23
FaceValue	10.00
Basic EPS (Rs.)	261.78
Diluted EPS (Rs.)	261.78
Cash EPS (Rs.)	279.35
Book Value[Excl.RevalReserv]/Share (Rs.)	441.39
Book Value[Incl.RevalReserv]/Share (Rs.)	441.39
Revenue From Operations / Share (Rs.)	1239.61
PBDIT / Share (Rs.)	377.83
PBIT / Share (Rs.)	360.61
PBT / Share (Rs.)	367.61
Net Profit / Share (Rs.)	262.13
NP After MI And SOA / Share (Rs.)	262.13
PBDIT Margin (%)	30.47
PBIT Margin (%)	29.09
PBT Margin (%)	29.65
Net Profit Margin (%)	21.14
NP After MI And SOA Margin (%)	21.14
Return on Networth / Equity (%)	59.38
Return on Capital Employeed (%)	77.98
Return On Assets (%)	35.15
Current Ratio (X)	1.92
Quick Ratio (X)	0.89
Dividend Payout Ratio (NP) (%)	139.85
Dividend Payout Ratio (CP) (%)	131.23
Earning Retention Ratio (%)	-39.85
Cash Earning Retention Ratio (%)	-31.23
Interest Coverage Ratio (X)	511.18
Interest Coverage Ratio (Post Tax) (X)	345.18
Enterprise Value (Cr.)	18147.83
EV / Net Operating Revenue (X)	6.37
EV / EBITDA (X)	20.88
MarketCap / Net Operating Revenue (X)	6.51
Retention Ratios (%)	-39.85
Price / BV (X)	18.28
Price / Net Operating Revenue (X)	6.51
EarningsYield	0.03

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Sanofi India Ltd as of December 30, 2024 is: 5,265.84

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 30, 2024, Sanofi India Ltd is Overvalued by 13.84% compared to the current share price 6,112.00

Intrinsic Value of Sanofi India Ltd as of December 30, 2024 is: 5,376.43

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 30, 2024, Sanofi India Ltd is Overvalued by 12.03% compared to the current share price 6,112.00

Last 5 Year EPS CAGR: 2.10%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 32.42%, which is a positive sign. The stock has a low average Working Capital Days of 17.58, which is a positive sign. The company has higher reserves (1,635.08 cr) compared to borrowings (8.69 cr), indicating strong financial stability. The company has shown consistent growth in sales (1.85 cr) and profit (522.46 cr) over the years.	The stock has a high average Cash Conversion Cycle of 73.17, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sanofi India Ltd:
1. Net Profit Margin: 21.14%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 77.98% (Industry Average ROCE: 16.01%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 59.38% (Industry Average ROE: 15.93%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 345.18
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.89
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 33.4 (Industry average Stock P/E: 45.18)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Sanofi India Ltd. is a Public Limited Listed company incorporated on 02/05/1956 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1956PLC009794 and registration number is 009794. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2956.60 Cr. and Equity Capital is Rs. 23.00 Cr. for the Year ended 31/12/2021.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	Sanofi House, Mumbai Maharashtra 400072	igrc.sil@sanofi.com http://www.sanofiindialtd.com

Management
Name	Position Held
Mr. Aditya Narayan	Chairman & Ind.Director
Mr. Rodolfo Hrosz	Managing Director
Mr. Rachid Ayari	WholeTime Director & CFO
Ms. Renee Amonkar	Whole Time Director
Mr. Vaibhav Karandikar	Non Executive Director
Mrs. Usha Thorat	Independent Director
Mr. Rahul Bhatnagar	Independent Director

FAQ

What is the latest intrinsic value of Sanofi India Ltd?

The latest intrinsic value of Sanofi India Ltd as on 30 December 2024 is ₹5265.84, which is 13.84% lower than the current market price of ₹6,112.00. The stock has a market capitalization of 14,076 Cr. and recorded a high/low of 7,600/4,606 during the current fiscal year 2024-2025. As of Jun 2024, the company has reserves of ₹662 Cr and total liabilities of ₹1,360 Cr.

What is the Market Cap of Sanofi India Ltd?

The Market Cap of Sanofi India Ltd is 14,076 Cr..

What is the current Stock Price of Sanofi India Ltd as on 30 December 2024?

The current stock price of Sanofi India Ltd as on 30 December 2024 is 6,112.

What is the High / Low of Sanofi India Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Sanofi India Ltd stocks is 7,600/4,606.

What is the Stock P/E of Sanofi India Ltd?

The Stock P/E of Sanofi India Ltd is 33.4.

What is the Book Value of Sanofi India Ltd?

The Book Value of Sanofi India Ltd is 298.

What is the Dividend Yield of Sanofi India Ltd?

The Dividend Yield of Sanofi India Ltd is 2.73 %.

What is the ROCE of Sanofi India Ltd?

The ROCE of Sanofi India Ltd is 71.1 %.

What is the ROE of Sanofi India Ltd?

The ROE of Sanofi India Ltd is 51.5 %.

What is the Face Value of Sanofi India Ltd?

The Face Value of Sanofi India Ltd is 10.0.